Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Chlorhexidine
Drug ID BADD_D00434
Description Chlorhexidine is a broad-spectrum antimicrobial biguanide used as a topical antiseptic and in dental practice for the treatment of inflammatory dental conditions caused by microorganisms.[L11512] It is one of the most common skin and mucous membrane antiseptic agents in use today.[A190417] The molecule itself is a cationic bis-guanide consisting of two 4-chlorophenyl rings and two biguanide groups joined by a central hexamethylene chain.[A190453] Topical chlorhexidine for disinfection, as well as oral rinses for dental use, carries activity against a broad range of pathogens including bacteria, yeasts, and viruses.[L11518,L11512,A190453] Chlorhexidine was developed in the UK by Imperial Chemical Industries in the early 1950s[A190474] and was introduced to the US in the 1970s.[L11572]
Indications and Usage Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures.[L11518,L11521,L11527,L11533] Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis[L11512] and a slow-release "chip" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.[L11536]
Marketing Status approved; vet_approved
ATC Code A01AB03; B05CA02; D08AC02; D09AA12; R02AA05; S01AX09; S02AA09; S03AA04
DrugBank ID DB00878
KEGG ID D07668
MeSH ID D002710
PubChem ID 9552079
TTD Drug ID D0V4GY
NDC Product Code 76107-135; 53296-0010
UNII R4KO0DY52L
Synonyms Chlorhexidine | Chlorhexidine Hydrochloride | Hydrochloride, Chlorhexidine | Tubulicid | Novalsan | Sebidin A | Chlorhexidine Acetate | Acetate, Chlorhexidine | MK-412A | MK 412A | MK412A
Chemical Information
Molecular Formula C22H30Cl2N10
CAS Registry Number 55-56-1
SMILES C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.0010.000203%Not Available
Abscess11.01.08.001--Not Available
Ageusia17.02.07.001; 07.14.03.0030.000516%Not Available
Anaphylactic reaction24.06.03.006; 10.01.07.0010.000184%
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Aphthous ulcer07.05.06.0020.000203%Not Available
Application site reaction12.07.01.006; 08.02.01.006--Not Available
Aptyalism07.06.01.001--Not Available
Arthralgia15.01.02.001--
Arthropathy15.01.01.003--Not Available
Back pain15.03.04.005--
Blister23.03.01.001; 12.01.06.002--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Burning sensation17.02.06.001; 08.01.09.0290.000516%Not Available
Cardiac arrest02.03.04.001--
Cough22.02.03.001--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Discomfort08.01.08.003--Not Available
Drug hypersensitivity10.01.01.0010.000359%Not Available
Dry mouth07.06.01.002--
Dry skin23.03.03.001--
Dysgeusia17.02.07.003; 07.14.03.001--
Dysmenorrhoea21.01.01.002--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.11.05.0030.000341%
Eczema23.03.04.006--
Erythema23.03.06.0010.000295%Not Available
Eye irritation06.04.05.0030.000203%Not Available
Eye pain06.08.03.0020.000184%
Face oedema08.01.07.003; 23.04.01.004; 10.01.05.002--
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene